In the News

Connect with us

Stay Informed.
Get the latest news and updates on MSK’s cancer care and research breakthroughs sent straight to your inbox with our e-newsletters.
Newsletter Sign Up
501 News Items found
Hyperpolarized MRI
In the Clinic
Hyperpolarized MRI: A New Tool to Assess Treatment Response within Days

Hyperpolarized MRI could allow doctors to get a read on a tumor’s response to treatment quickly.
Two doctors looking at a patient
Q&A
Answers to Common Questions about Radiation Safety

MSK radiation therapy experts set the record straight about the safety of this effective treatment.
(From left) The first four authors of the June 24 Cancer Cell study, Barry Taylor, Anuradha Gopalan, Haley Hieronymous, and Nikolaus Schultz.
Sifting Through the Prostate Cancer Genome

A team of Memorial Sloan Kettering clinicians and computational biologists have compiled the largest catalog to date of genetic alterations that occur in prostate cancer.
Charles Sawyers in his lab
A New Approach in Prostate Cancer: Targeting the Cells Surrounding the Tumor

Scientists have found a protein that empowers prostate tumors to resist hormone therapy.
Laboratory coats hanging from pegs
MSK Research Highlights, November 23, 2022

New research from Memorial Sloan Kettering Cancer Center (MSK) and the Sloan Kettering Institute finds tumor-associated macrophages that express a specific transcription factor might be targeted to improve immunotherapy; examines how different mutational processes impact individual cell genomes in cancer; sheds new light on cell senescence in cancer; and offers new models to aid the search for new treatments for mesothelioma.
Image of As, Ts, Cs, and Gs representing genetic code
Announcement
AACR Project GENIE Seeks to Advance Cancer Treatment

Eight leading cancer centers are coming together to share genomic sequencing data, in the hope of making faster progress in curing cancer.
photo of sample blood vials
Finding
Could a Blood Test Detect Early-Stage Cancers?

A sensitive assay for detecting tumor DNA in the blood performed well in patients and may herald the development of a blood test for cancer screening.
Computational biologist Quaid Morris
In the Lab
Machine Learning Helps Clarify the Risk Connected to Age-Related Blood Condition

A new study shows how evolution and natural selection influence clonal hematopoiesis, an aging-related blood condition that increases the risk of blood cancer and cardiovascular disease.
MD-PhD Candidate Brandon Cuevas in an MSK lab
The Next Generation of Cancer Researchers: Brandon Cuevas

Meet Cancer Engineering MD-PhD candidate Brandon Cuevas: “Being able to be a bridge between medicine and research is such a privilege, one that not many places can offer.”
Simon Powell
An Interview With Simon Powell

Dr. Powell joined Memorial Sloan Kettering in 2008 as Chair of the Department of Radiation Oncology with a joint appointment in Sloan Kettering Institute's Molecular Biology Program.